Viral Vitalism

Source Library

FDA approves Zepbound as first medication for obstructive sleep apnea in adults with obesity

U.S. Food and Drug Administration is tracked in the Viral Vitalism canonical source library.

GovernmentU.S. health regulator
Source type
Government
Access type
Official
Publisher
U.S. Food and Drug Administration
Date
2024-12-20
Added
2026-06-19
Open original ->Source index

Trust profile

VV Source Trust Matrix v1.0

VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.

94

U.S. health regulator

Publisher type
Regulator
Bias profile
Low

This source is strongest for regulatory status and safety and weaker for consumer context and trial discovery.

VV Source Fit Score 1.0

Fit by use case

Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.

Frameworks ->
Regulatory status
98/100
Primary Anchor
Clinical outcomes
84/100
Strong Support
Mechanism
68/100
Context Source
Safety
95/100
Primary Anchor
Consumer context
68/100
Context Source
Trial discovery
68/100
Context Source

Best used for

  • Approvals
  • Labels
  • Safety communications

Weak for

  • Comparative effectiveness
  • Consumer experience

Used in Viral Vitalism

Claim ledger

Claims supported

Reviewed claim cards that cite this source in the evidence graph.

supported86/100

tirzepatide: Tirzepatide improved obstructive sleep apnea outcomes in adults with

Tirzepatide improved obstructive sleep apnea outcomes in adults with obesity in SURMOUNT-OSA.

Strong human evidence3 sources

Related studies

SURMOUNT-OSATirzepatide for the treatment of obstructive sleep apnea and obesity

Related sources

Topic tags

glp-1tirzepatidezepboundsleep-apneaobesity

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No selling your information. Unsubscribe anytime.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.